Well, the market cap lower-is-better factor is only 5% of the ranking system. You could eliminate that easily with little effect. There is no volume lower-is-better factor. There’s share turnover, which doesn’t reward small caps at all. The companies with the lowest share turnover in the SP 500 are Walmart, Johnson & Johnson, and Exxon Mobil.
And don’t substitute other backtest steroids such as sales lower is better, assets lower is better, etc. Those will inhibit your ability to learn to address large caps. I hate seeing factors like that. The only functions they serve are to hope the risk-on not-really-existent small cap effect are permanent and to juice backtest results.
I wouldn’t dream of doing so. In fact I regularly use the opposite factors (sales higher is better, assets higher is better) to moderate the “market cap lower is better” factor, which can have pernicious effects on occasion.
Don’t try to get an equity curve that looks like a 45 degree - plus angle with the benchmark as a nearly horizontal base. In fact, if your simulated alpha clocks in a more than 3%, go back and revise the system because there’s a good chance you’re data mining.
Here I really disagree. The object of using P123 is to improve your probability of getting good returns. You can’t get good returns by curve-fitting–on that we agree. But if you figure out how to incrementally improve a good strategy’s backtested results, you’re also incrementally improving your own. Improving a ranking system by improving its past performance gives you a slightly higher chance of improving out-of-sample returns than sticking with an unimproved ranking system. The logical conclusion is that you should improve your ranking system as much as possible, and aim for the highest backtested returns, as that will give you the highest probability of high out-of-sample returns. You just have to use robust backtesting by using rolling tests and very large sample sizes (weekly is better than monthly, 100 stocks better than fifty, large universes better than small, very long backtest periods better than short ones) to ensure you’re not curve-fitting, and you have to look carefully at your returns distribution, and you have to carefully research all your factors and rules to make sure they make good financial sense. (I have frequently “improved” a factor by making it make more “sense” even if the backtested returns went down by doing so.)
I realize that you can design a very attractive backtest using complicated buy and sell rules and a small number of stocks, and that those strategies are basically worthless. But that shouldn’t invalidate efforts to incrementally improve backtested returns in order to incrementally improve a strategy using robust methods that correlate well between in-sample and out-of-sample periods. And if those backtests show alphas of 40%, fine.